Journal metric profile

METABOLIC BRAIN DISEASE

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 3.500 2025 metric year
5-Year Impact Factor 3.600 Longer citation window
JCR Quartile Q2 Subject-category quartile
JCR Category Rank 109/314 Recorded category rank

METABOLIC BRAIN DISEASE JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

METABOLIC BRAIN DISEASE metric snapshot

METABOLIC BRAIN DISEASE has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is SPRINGER/PLENUM PUBLISHERS. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 3.500. The five-year Journal Impact Factor is 3.600, giving a second citation window for comparison. The journal is recorded in quartile Q2 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 109 out of 314 journals. Based on that rank position, the journal sits within approximately the top 35% of the listed category. Its listed quartile is Q2. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (3.600) is 0.100 points higher than the standard Journal Impact Factor (3.500). Without journal self-citations, the Impact Factor is 3.400, a difference of 0.100 points from the listed standard value. The Journal Citation Indicator (JCI) is recorded as 0.810. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for METABOLIC BRAIN DISEASE lists total cites: 6,345; total articles: 128; citable items: 161. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 5.4 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 7.1 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

METABOLIC BRAIN DISEASE is identified in this directory by print ISSN 0885-7490 and electronic ISSN 1573-7365. The publisher is recorded as SPRINGER/PLENUM PUBLISHERS. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameMETABOLIC BRAIN DISEASE
Abbreviated journalMETAB BRAIN DIS
PublisherSPRINGER/PLENUM PUBLISHERS
Metric year2025
Overall rank3,784
ISSN0885-7490
eISSN1573-7365
Total cites6,345
Total articles128
Citable items161
Cited half-life5.4 years
Citing half-life7.1 years
JCR-based Journal Impact Factor3.500
5-Year Impact Factor3.600
Impact Factor without journal self-cites3.400
Journal Citation Indicator0.810
JCR Impact Factor quartileQ2
JCR category rank109/314
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of METABOLIC BRAIN DISEASE?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for METABOLIC BRAIN DISEASE is 3.500 for the 2025 metric year.

What are the JCR quartile and category rank of METABOLIC BRAIN DISEASE?

METABOLIC BRAIN DISEASE is listed with quartile Q2 and category rank 109/314. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of METABOLIC BRAIN DISEASE?

The five-year Journal Impact Factor recorded for METABOLIC BRAIN DISEASE is 3.600. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes METABOLIC BRAIN DISEASE?

METABOLIC BRAIN DISEASE is listed in this directory as being published by SPRINGER/PLENUM PUBLISHERS.

Additional records from the same publisher or with a similar listed JCR Impact Factor.